Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Members of the House Subcommittee on Research and Technology heard testimony September 18 regarding how science may help combat methamphetamine (meth) addiction.
More than 14 million individuals worldwide are believed to be using amphetamine-type stimulants for nonmedical purposes. In the United States, in 2010, almost 6% of admissions to publicly funded drug treatment programs were for amphetamine-related problems.
Edythe D. London, PhD, professor of addiction studies at the David Geffen School of Medicine, University of California, Los Angeles, testified before the subcommittee that more than 2 decades of concerted efforts have failed to produce broadly effective pharmaceutical medications for meth dependence and that behavioral treatments, while effective, have high dropout rates.
Mitka M. Researchers Promote Science to Curb Methamphetamine Addiction. JAMA. 2013;310(18):1912. doi:10.1001/jama.2013.281413